Sign in
CompletedNo phase

Circadian Variation in Esophagogastric Variceal Bleeding in Cirrhosis

Key facts

Who runs it
Third Affiliated Hospital, Sun Yat-Sen University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
614 people enrolled
Started
1 Jul 2025
Ended
1 Nov 2026
Type of study
Observational
Record updated
17 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Aged 18 years or older
  • Clinically diagnosed with liver cirrhosis
  • Evident signs of acute upper gastrointestinal bleeding, specifically acute upper gastrointestinal bleeding presenting as hematemesis
  • Informed consent

Who cannot take part

  • Non-variceal bleeding detected by gastroscopy
  • Severe extrahepatic diseases with cardiac, pulmonary, renal or cerebral insufficiency, excluding hepatic encephalopathy, hepatorenal syndrome and hepatopulmonary syndrome caused by liver cirrhosis
  • Comorbidity with malignant tumors other than primary liver cancer
  • Pregnant or breastfeeding women

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a multi-center bidirectional cohort study. The aim is to investigate the potential circadian rhythm of the bleeding pattern of gastric esophageal varices rupture in liver cirrhosis, as well as other related mechanisms and external influencing factors related to the timing. This will help to better prevent the occurrence or aggravation of the disease and provide more effective timing-based treatment and prevention strategies for patients.

The group in the trial

  • Population with Cirrhosis-related Variceal Bleeding

    Inclusion Criteria 1. Aged 18 years or above 2. Clinically diagnosed with liver cirrhosis 3. Presenting with overt acute upper gastrointestinal bleeding, specifically hematemesis 4. Informed consent obtained Exclusion Criteria (1) Non-variceal bleeding identified on gastroscopy (2) Severe extrahepatic diseases, including cardiopulmonary, renal, or cerebral insufficiency, excluding hepatic encephalopathy, hepatorenal syndrome, and hepatopulmonary syndrome secondary to liver cirrhosis (3) Concurrent malignancy other than primary liver cancer (4) Pregnant or breastfeeding women

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Circadian Variation in Esophagogastric Variceal Bleeding in Cirrhosis: A Prospective, Multicenter, Cross-Sectional Study
Record updated
17 November 2026